Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flavia FranconifiledCriticalFlavia Franconi
Priority to IT92MI002040ApriorityCriticalpatent/ITMI922040A1/en
Publication of ITMI922040A0publicationCriticalpatent/ITMI922040A0/en
Publication of ITMI922040A1publicationCriticalpatent/ITMI922040A1/en
La somministrazione di taurina a pazienti affetti da iperaggregabilitĂ piastrinica, in particolare pazienti aterosclerotici e diabetici, riduce l'aggregazione piastrinica quantitativamente e come velocitĂ di aggregazione.The administration of taurine to patients with platelet hyperaggregability, in particular atherosclerotic and diabetic patients, reduces platelet aggregation both quantitatively and as an aggregation rate.
IT92MI002040A1992-09-011992-09-01
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PLATELET HYPERAGGREGABILITY STATES
ITMI922040A1
(en)